PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34694252-6	2022	The revised raltegravir pediatric kit and IFU (to include neonatal dosing) were approved by the US Food and Drug Administration in 2017 and the European Union in 2018.	Raltegravir Potassium	12-23	KIT proto-oncogene, receptor tyrosine kinase	Homo sapiens	34-37